Menu

An expert resource for medical professionals
Provided FREE as a service to women’s health

The Alliance for
Global Women’s Medicine
A worldwide fellowship of health professionals working together to
promote, advocate for and enhance the Welfare of Women everywhere

An Educational Platform for FIGO

The Global Library of Women’s Medicine
Clinical guidance and resourses

A vast range of expert online resources. A FREE and entirely CHARITABLE site to support women’s healthcare professionals

The Global Academy of Women’s Medicine
Teaching, research and Diplomates Association

Contraception 2015 Sep 10. pii: S0010-7824(15)00572-7.

Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review

Callahan R, Yacobson I, Halpern V and Nanda K

Abstract

Background: Use of contraception lowers a woman's risk of experiencing an ectopic pregnancy. In the case of method failure, however, progestin-only contraceptives may be more likely to result in ectopic pregnancies than some other methods such as combined hormonal and barrier contraceptives.

Objective: To describe ectopic pregnancy risk associated with use of implants and progestin-only injectable contraceptives through a systematic review of published studies.

Data sources: We searched electronic databases for articles in any language published through May 2015 describing studies of progestin-only injectables and implants. We also searched bibliographies and review articles for additional studies.

Study selection and extraction: Studies that reported any pregnancies were included in the review. Independent data extraction was performed by two authors based on predefined data fields and, where possible, we calculated the proportion of pregnancies that were ectopic and the ectopic pregnancy incidence rate per 1000 woman-years.

Results: Fifty-three studies of implants and 28 studies of injectables were identified, 79% reported pregnancy location. The proportion of ectopic pregnancy ranged from 0-100% with an incidence of 0-2.9 per 1000 woman-years in studies of marketed levonorgestrel (LNG) implants. Studies of etonogestrel (ENG) implants and the injectables, depot-medroxyprogesterone acetate (DMPA) and norethisterone enanthate (NET-EN), reported few ectopic pregnancies.

Conclusion:Progestin-only contraceptive implants and injectables protect against ectopic pregnancy by being highly effective in preventing pregnancy overall; however, the absolute risk of ectopic pregnancy varies by type of progestin. Risk of ectopic pregnancy should not be a deterrent for use or provision of these methods.

Comment: Health workers are often afraid that the administration of estrogen-free contraceptives will increase the risk of ectopic pregnancy. This is not the case; these products protect against all pregnancies, including ectopics. So, although no method is 100% effective, fear of ectopic pregnancy should never be a reason not to prescribe these effective methods (HMV).